| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bba842fc4d37dfcaced1b55bc0c91c7c |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04 |
| filingDate |
1975-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19dcf017f171d5d75742921257286fde
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e2fedcc571eae1349caea72aba0f923 |
| publicationDate |
1979-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CH-611899-A5 |
| titleOfInvention |
Process for the preparation of novel thieno[3,2-c]pyridine derivatives |
| abstract |
The compounds of the formula I <IMAGE> (for the meaning of the symbols R, R1 and R2 see Patent Claim 1) have adrenergic ss-blocking, antiarrhythmic, antilipolytic and antihyperglycaemic properties. They can be used as medicines. They are prepared from the aminoalcohol of the formula <IMAGE> by etherification. |
| priorityDate |
1975-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |